SINT · SINTX Technologies Inc

-

Please sign in to comment on SINT

1 Comment

Admin

4 years ago

Sintx Technologies, Inc is currently in a long term downtrend where the price is trading 9.0% below its 200 day moving average.

From a valuation standpoint, the stock is 96.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 54.0.

Sintx Technologies, Inc's total revenue sank by 53.6% to $117K since the same quarter in the previous year.

Its net income has increased by 99.8% to $-2K since the same quarter in the previous year.

Finally, its free cash flow fell by 6.9% to $-2M since the same quarter in the previous year.

Based on the above factors, Sintx Technologies, Inc gets an overall score of 2/5.

Exchange	NASDAQ
CurrencyCode	USD
Industry	Medical Devices
ISIN	US8293923079
Sector	Healthcare

PE Ratio	None
Beta	1.12
Target Price	30
Market Cap	7M
Dividend Yield	None

ABOUT

SINTX Technologies Inc

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

SINT · SINTX Technologies Inc

-

SINTX Technologies Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest SINTX Technologies Inc using a moving average strategy